04:13 PM EDT, 05/29/2024 (MT Newswires) -- Reshma Kewalramani, Director, CEO & President, on May 24, 2024, sold 1,565 shares in Vertex Pharmaceuticals ( VRTX ) for $715,205. Following the Form 4 filing with the SEC, Kewalramani has control over a total of 121,374 shares of the company, with 121,374 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/875320/000087532024000160/xslF345X03/wk-form4_1717013304.xml